59 completed, 10 terminated, 2 withdrawn, 1 unknown. 72 Phase 1, 10 Phase 2.
By phase and status
Follow Abbott: new trials by email
Trials (filtered) newest first · largest first
All 72 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects Cortiment, Budesonide - Healthy Subjects, Human Volunteers | Phase 1 | Completed | 56 | 2021-07-12 | 2022-08-29 |
Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxacin) Under Fasting Condition in Healthy Adult Pakistani Subjects Moksi® 400mg Tablet, Drug: Avelox® 400Mg Tablet - Bioequivalence | Phase 1 | Completed | 38 | 2019-03-27 | 2022-04-01 |
Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status Veliparib, Topotecan - Ovarian Cancer | Phase 1 / Phase 2 | Completed | 22 | 2012-11-01 | 2015-06-10 |
A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease ABT-126, Placebo - Alzheimer's Disease | Phase 1 | Completed | 20 | 2011-11-01 | 2012-05-02 |
Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Veliparib - Recurrent, Epithelial Ovarian Cancer | Phase 1 / Phase 2 | Completed | 49 | 2011-11-01 | 2016-11-16 |
A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine. ABT-614, Placebo Comparator - Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine | Phase 1 | Completed | 16 | 2011-11-01 | 2012-08-22 |
A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors linifanib - Advanced or Metastatic Solid Tumors | Phase 1 | Terminated | 14 | 2011-10-01 | 2012-08-28 |
Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma ABT-888/Bortezomib - Multiple Myeloma | Phase 1 | Completed | 19 | 2011-10-01 | 2017-09-25 |
A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors. [14C]linifanib, ABT-869, linifanib - Advanced Solid Tumors | Phase 1 | Terminated | 3 | 2011-08-01 | 2012-09-21 |
Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors Linifanib, Rifampin - Advanced Solid Tumors | Phase 1 | Completed | 14 | 2011-05-01 | 2011-11-02 |
To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. linifanib - Advanced Solid Tumors | Phase 1 | Completed | 13 | 2011-05-01 | 2012-03-23 |
A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia SLV354 - Schizophrenia | Phase 1 | Completed | 18 | 2011-05-01 | 2012-09-18 |
Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates. briakinumab - Moderate to Severe Plaque Psoriasis | Phase 1 | Withdrawn | 12 | 2011-04-01 | 2011-10-21 |
Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males. ABT-SLV361, placebo - Hypogonadal Males | Phase 1 | Completed | | 2011-04-01 | 2011-11-03 |
ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer ABT-888, mFOLFOX-6 - Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | Completed | 64 | 2011-01-03 | 2025-11-06 |
Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut FITC-Adalimumab - Crohn's Disease | Phase 1 / Phase 2 | Completed | 25 | 2011-01-01 | 2012-09-14 |
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness ABT-652, Placebo - Sleep Disorder | Phase 1 | Completed | 36 | 2010-08-01 | 2011-07-04 |
Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects ABT-267, Placebo, Blood Sample Collection - HCV Infection | Phase 1 | Completed | 137 | 2010-08-01 | 2012-01-24 |
Influence of Male Hormones on Regional Fat Metabolism Leuprolide, Testosterone - Obesity | Phase 1 | Completed | 39 | 2010-06-01 | 2014-05-14 |
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869) ABT-869, ketoconazole - Solid Tumors | Phase 1 | Completed | 12 | 2010-05-01 | 2011-07-26 |
Showing 20 of 72. Sign in to see all of them.
Conditions studied
Hepatitis C (11) · HIV Infections (4) · Carcinoma, Non-Small-Cell Lung (3) · Acquired Immunodeficiency Syndrome (2) · Alzheimer Disease (2) · Carcinoma, Ovarian Epithelial (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lung Neoplasms (2) · Lymphoma (2) · Multiple Myeloma (2) · Neoplasms (2) · Ovarian Neoplasms (2) · Recurrence (2) · Schizophrenia (2) · AIDS-Related Complex (1)
Interventions
linifanib (6) · ABT-072 (5) · ABT-126 (5) · Ketoconazole (4) · dasabuvir (4) · navitoclax (4) · ABT751 (3) · Lopinavir (3) · Ritonavir (3) · paritaprevir (3) · veliparib (3) · 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid (2) · Bevacizumab (2) · Carboplatin (2) · Docetaxel (2)
Countries
United States (57) · Canada (4) · United Kingdom (3) · Denmark (2) · Japan (2) · Netherlands (2) · Germany (1) · India (1) · Ireland (1) · Pakistan (1)
Top investigators
Daniel Cohen, MD (4) · Mark D. McKee, MD (3) · Isabelle A Gaultier, M.S., IBMH (2) · Mihail Obrocea, MD (2) · Adebayo Lawal, M.D. (1) · Anders Jakobsen, DMSc (1) · Anders Jakobsen, MD, DMSc (1) · Andrew Campbell, MD (1) · Angela Nilius, MD (1) · Anil Singhal, PhD (1) · Beatrice Rendenbach-Mueller, PhD (1) · Bela Denes, MD (1) · Cathey Powers, MD (1) · Daniel Cohen (1) · David A Williams, MD (1)
Results publications
PMID 19440247, PMID 21377273, PMID 23147218, PMID 25451055, PMID 30104007, PMID 33849298
NIH funding
2008 (2), 2009 (1), R01DK045343 (1)